Frederick M. Wigley

1.8k total citations
21 papers, 1.0k citations indexed

About

Frederick M. Wigley is a scholar working on Pathology and Forensic Medicine, Dermatology and Epidemiology. According to data from OpenAlex, Frederick M. Wigley has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 7 papers in Dermatology and 7 papers in Epidemiology. Recurrent topics in Frederick M. Wigley's work include Systemic Sclerosis and Related Diseases (17 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Dermatologic Treatments and Research (6 papers). Frederick M. Wigley is often cited by papers focused on Systemic Sclerosis and Related Diseases (17 papers), Inflammatory Myopathies and Dermatomyositis (7 papers) and Dermatologic Treatments and Research (6 papers). Frederick M. Wigley collaborates with scholars based in United States, United Kingdom and Switzerland. Frederick M. Wigley's co-authors include Joseph C. Shipp, Robert H. Waldman, Ari Zaiman, Maureen D. Mayes, Peter A. Merkel, Viswanathan Natarajan, Joe G. N. Garcia, Eddie T. Chiang, Kane L. Schaphorst and Barri J. Fessler and has published in prestigious journals such as Gastroenterology, PLoS ONE and Diabetes.

In The Last Decade

Frederick M. Wigley

21 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick M. Wigley United States 14 548 259 250 238 238 21 1.0k
Takashi Yamashita Japan 21 627 1.1× 260 1.0× 204 0.8× 290 1.2× 429 1.8× 70 1.2k
Takemichi Fukasawa Japan 17 514 0.9× 181 0.7× 228 0.9× 175 0.7× 302 1.3× 71 1.0k
Ryosuke Saigusa Japan 20 630 1.1× 240 0.9× 232 0.9× 439 1.8× 764 3.2× 59 1.5k
Bianca Marasini Italy 20 427 0.8× 129 0.5× 107 0.4× 131 0.6× 218 0.9× 56 1.2k
D. Adoué France 17 247 0.5× 72 0.3× 195 0.8× 152 0.6× 112 0.5× 75 884
Barbora Šumová Czechia 12 179 0.3× 75 0.3× 169 0.7× 306 1.3× 169 0.7× 14 711
Terence T. Casey United States 13 381 0.7× 230 0.9× 60 0.2× 320 1.3× 187 0.8× 22 940
Lisa Hamilton United Kingdom 19 413 0.8× 134 0.5× 144 0.6× 77 0.3× 220 0.9× 45 1.1k
M Koss United States 18 299 0.5× 38 0.1× 539 2.2× 233 1.0× 105 0.4× 28 1.5k
Yuko Shima Japan 19 312 0.6× 38 0.1× 211 0.8× 428 1.8× 113 0.5× 61 1.2k

Countries citing papers authored by Frederick M. Wigley

Since Specialization
Citations

This map shows the geographic impact of Frederick M. Wigley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick M. Wigley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick M. Wigley more than expected).

Fields of papers citing papers by Frederick M. Wigley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick M. Wigley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick M. Wigley. The network helps show where Frederick M. Wigley may publish in the future.

Co-authorship network of co-authors of Frederick M. Wigley

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick M. Wigley. A scholar is included among the top collaborators of Frederick M. Wigley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick M. Wigley. Frederick M. Wigley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mecoli, Christopher A., Laura Gutierrez‐Alamillo, Qingyuan Yang, et al.. (2021). PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays. Clinical Rheumatology. 40(7). 2763–2769. 5 indexed citations
2.
Shah, Ami A., Antony Rosen, Laura K. Hummers, et al.. (2017). Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease.. PubMed. 35 Suppl 106(4). 71–74. 17 indexed citations
3.
McMahan, Zsuzsanna H., Frederick M. Wigley, & Livia Casciola‐Rosen. (2016). Risk of Digital Vascular Events in Scleroderma Patients Who Have Both Anticentromere and Anti–Interferon‐Inducible Protein 16 Antibodies. Arthritis Care & Research. 69(6). 922–926. 12 indexed citations
5.
Cheadle, Chris, Alan E. Berger, Stephen C. Mathai, et al.. (2012). Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients. PLoS ONE. 7(4). e34951–e34951. 53 indexed citations
6.
Matucci‐Cerinic, Marco, CP Denton, D.E. Furst, et al.. (2010). Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases. 70(1). 32–38. 322 indexed citations
8.
Soong, T. Rinda, Lili A. Barouch, Hunter C. Champion, Frederick M. Wigley, & Marc K. Halushka. (2007). New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy—a report of 2 cases. Human Pathology. 38(12). 1858–1863. 42 indexed citations
9.
Hummers, Laura K., et al.. (2007). High-dose cyclophosphamide without stem cell rescue in scleroderma. Annals of the Rheumatic Diseases. 67(6). 775–781. 21 indexed citations
10.
Schaphorst, Kane L., Eddie T. Chiang, Ari Zaiman, et al.. (2003). Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. American Journal of Physiology-Lung Cellular and Molecular Physiology. 285(1). L258–L267. 147 indexed citations
11.
Rencic, Adrienne, et al.. (2002). Bullous lesions in scleroderma. International Journal of Dermatology. 41(6). 335–339. 20 indexed citations
12.
Wigley, Frederick M.. (2001). Raynaud's phenomenon is linked to unopposed estrogen replacement therapy in postmenopausal women.. PubMed. 19(1). 10–1. 5 indexed citations
13.
Matsumoto, Alan K., Robert G. Moore, Patricia M. Alli, & Frederick M. Wigley. (2000). Three cases of osteonecrosis of the lunate bone of the wrist in scleroderma.. PubMed. 17(6). 730–2. 17 indexed citations
14.
Wigley, Frederick M., et al.. (2000). The treatment of scleroderma. 2(4). 276–292. 1 indexed citations
15.
Jabs, Ethylin Wang, Cathy M. Tuck‐Müller, Grant J. Anhalt, et al.. (1993). Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies. Cytogenetic and Genome Research. 63(3). 169–175. 11 indexed citations
16.
Wigley, Frederick M.. (1991). The Differential Diagnosis of Raynaud's Phenomenon. Hospital Practice. 26(7). 63–84. 3 indexed citations
17.
Whitehead, William E., Greta Taitelbaum, Frederick M. Wigley, & Marvin M. Schuster. (1989). Rectosigmoid Motility and Myoelectric Activity in Progressive Systemic Sclerosis. Gastroenterology. 96(2). 428–432. 33 indexed citations
18.
Wise, Robert A., et al.. (1988). HLA-DQw Alloantigens and Pulmonary Dysfunction in Rheumatoid Arthritis. CHEST Journal. 94(3). 609–614. 3 indexed citations
19.
Wigley, Frederick M., et al.. (1987). Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets.. PubMed. 14(3). 512–8. 35 indexed citations
20.
Wise, Robert A., Frederick M. Wigley, Harold H. Newball, & Mary Betty Stevens. (1982). The Effect of Cold Exposure on Diffusing Capacity in Patients with Raynaud's Phenomenon. CHEST Journal. 81(6). 695–698. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026